CAW
WX

Cornerstone Advisors (Washington)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-986
Closed -$43K – 943
2015
Q3 		$43K Buy
+986
New +$41.6K 0.04% 195

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Cornerstone Advisors (Washington)'s WX Position: Q4 2015 in Review

Cornerstone Advisors (Washington) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 986 shares — an estimated $43K sold.

Cornerstone Advisors (Washington) first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $43K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Cornerstone Advisors (Washington) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 986 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $43K.
  • Cornerstone Advisors (Washington) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Cornerstone Advisors (Washington)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $43K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q4 2015, filed 28 Jan 2016.